SCHEDULE 13G/A: William P. Scully Discloses 10.4% Beneficial Stake in Prothena Corp Public Ltd Co

William P. Scully has filed an amended Schedule 13G, revealing beneficial ownership of 10.4% of Prothena Corp Public Ltd Co's Ordinary Shares as of March 31, 2025.

Summary

• William P. Scully reported beneficial ownership of 5,607,748 Ordinary Shares of Prothena Corp Public Ltd Co.
• This ownership represents approximately 10.42% of the issuer's total outstanding shares, based on 53,826,982 shares outstanding as of February 20, 2025.
• Mr. Scully holds sole voting and dispositive power over 793,943 shares.
• He holds shared voting and dispositive power over 4,813,805 shares.
• The shares are held through various means, including direct ownership, an LLC (Manatee Equity Fund LLC), personal and spousal IRAs, trusts where he is a co-trustee, and grantor retained annuity trusts where he retains the right to substitute assets.

Sentiment

Score: 6

Explanation: The document is a factual disclosure of beneficial ownership. The significant stake (10.4%) by an individual investor could be perceived as a positive signal of confidence, but it does not contain performance or operational updates.

Positives

• A significant beneficial ownership stake of 10.4% by an individual investor like William P. Scully may signal confidence in the company's long-term prospects.
• The filing clarifies the diverse structures through which the beneficial ownership is maintained, indicating a structured investment approach.

Negatives

• The document is a disclosure of ownership and does not inherently contain negative financial or operational information about the company.

Risks

• The filing itself does not detail specific company risks, but rather the structure of beneficial ownership. The primary risk related to this document is the potential for misinterpretation of the ownership structure or its implications for corporate control, although the filing explicitly states the shares were not acquired for the purpose of changing or influencing control, other than activities solely in connection with a nomination under Rule 240.14a-11.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

This filing is a standard disclosure of beneficial ownership and does not provide specific insights into broader industry trends or competitive landscape for Prothena Corp Public Ltd Co.

Related Party Transactions

• 42,000 Ordinary Shares owned by the Reporting Person's spouse's IRA, over which he may be deemed to have shared voting and dispositive power.
• 5,000 Ordinary Shares owned by the Reporting Person's spouse, over which he may be deemed to have shared voting and dispositive power.
• 158,000 Ordinary Shares owned in the aggregate by various trusts, of which the Reporting Person may be deemed to have shared voting and dispositive power by virtue of being a co-trustee.
• 4,098,346 Ordinary Shares owned in the aggregate by various grantor retained annuity trusts, which have an independent trustee, but over which the Reporting Person may be deemed to have shared voting and dispositive power by reason of his retained right to substitute assets in such trusts.
• 492,459 Ordinary Shares owned in the aggregate by various other trusts, which have an independent trustee, but over which the Reporting Person may be deemed to have shared voting and dispositive power by reason of his retained right to substitute assets in such trusts.

Stakeholder Impact

• Shareholders: The disclosure of a significant beneficial ownership stake by an individual investor provides transparency regarding the company's ownership structure and may influence investor perception and confidence.

Key Dates

Keywords

Prothena Corp Public Ltd Co, William P. Scully, Schedule 13G, Beneficial Ownership, Ordinary Shares, SEC Filing, Shareholder, Investment, Corporate Governance